Alış
Güncellendi

CWBR cheap anti-aging stock

CWBR CohBar is a clinical stage biotechnology company which develops mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases.

CWBR closed few months ago a $15.0 Million Offering of Common Stock and Warrants at $0.72, so this is a safe upside in my opinion if you want to enter now.

Cantor Fitzgerald brokerage has a $2.5 price target for it.
İşlem aktif
CWBR Agrees To Merge With Morphogenesis To Advance Late-Stage Oncology Candidates

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.